Medical therapies with adult stem/progenitor cells (MSCs): A backward journey from dramatic results in vivo to the cellular and molecular explanations
暂无分享,去创建一个
[1] Ariel Miller,et al. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. , 2011, Autoimmunity reviews.
[2] Ben D. MacArthur,et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.
[3] Marilyn S. Rugg,et al. The molecular basis of inter-alpha-inhibitor heavy chain transfer on to hyaluronan. , 2007, Biochemical Society transactions.
[4] D. Prockop,et al. Adult Bone Marrow Stem/Progenitor Cells (MSCs) Are Preconditioned by Microenvironmental "Niches" in Culture: A Two-Stage Hypothesis for Regulation of MSC Fate , 2005, Science's STKE.
[5] H. Rubin. Multistage carcinogenesis in cell culture. , 2001, Developments in biologicals.
[6] G. Núñez,et al. Cutting Edge: Critical Role for Mesothelial Cells in Necrosis-Induced Inflammation through the Recognition of IL-1α Released from Dying Cells1 , 2008, The Journal of Immunology.
[7] A. Xiang,et al. Human Gingiva‐Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound Healing , 2010, Stem cells.
[8] D. Benayahu,et al. TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation*S⃞ , 2008, Journal of Biological Chemistry.
[9] J. F. Staples,et al. The respiratory effects of stanniocalcin-1 (STC-1) on intact mitochondria and cells: STC-1 uncouples oxidative phosphorylation and its actions are modulated by nucleotide triphosphates , 2007, Molecular and Cellular Endocrinology.
[10] Grace Y Chen,et al. Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.
[11] R. Pochampally,et al. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. , 2004, Blood.
[12] Darwin J. Prockop,et al. Mitochondrial transfer between cells can rescue aerobic respiration , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Friedenstein,et al. Stromal stem cells: marrow-derived osteogenic precursors. , 1988, Ciba Foundation symposium.
[14] D. Prockop,et al. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury , 2010, Proceedings of the National Academy of Sciences.
[15] Carl Nathan,et al. Nonresolving Inflammation , 2010, Cell.
[16] D. Prockop,et al. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. , 2011, Blood.
[17] A. Uccelli,et al. Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.
[18] J. Tschopp,et al. A pilot study of IL-1 inhibition by anakinra in acute gout , 2007, Arthritis research & therapy.
[19] Y. Wan. Regulatory T cells: immune suppression and beyond , 2010, Cellular and Molecular Immunology.
[20] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[21] D. Prockop,et al. Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[22] Julie V. Harness,et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.
[23] Naftali Kaminski,et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] Marie C. M. Lin,et al. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling , 2011, RNA biology.
[25] S. Raiden,et al. Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like Profile , 2010, PloS one.
[26] P. Rameshwar,et al. microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis. , 2011, Current cancer therapy reviews.
[27] J. Vilček,et al. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. , 2004, Cytokine & growth factor reviews.
[28] Donald G Phinney,et al. Defining the risks of mesenchymal stromal cell therapy. , 2010, Cytotherapy.
[29] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[30] N. Kulagina,et al. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. , 1976, Experimental hematology.
[31] B. Sacchetti,et al. Osteoprogenitors and the hematopoietic microenvironment. , 2011, Best practice & research. Clinical haematology.
[32] R. Pochampally,et al. Multipotent Stromal Cells Are Activated to Reduce Apoptosis in Part by Upregulation and Secretion of Stanniocalcin‐1 , 2009, Stem cells.
[33] D. Prockop. Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.
[34] R. Romieu-Mourez,et al. Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype1 , 2009, The Journal of Immunology.
[35] M. Abdelrahim,et al. Stanniocalcin-1 Suppresses Superoxide Generation in Macrophages through Induction of Mitochondrial Ucp2 , 2008 .
[36] M. Kay,et al. Sarcoma Derived from Cultured Mesenchymal Stem Cells , 2007, Stem cells.
[37] Fernando Ontiveros,et al. The sterile inflammatory response. , 2010, Annual review of immunology.
[38] R. Zhao,et al. The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. , 2011, Experimental Hematology.
[39] D. Prockop,et al. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[40] R. Zhao,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.
[41] R. Medzhitov. Innate immunity: quo vadis? , 2010, Nature Immunology.
[42] Y. Fujiyoshi,et al. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts , 2011, Proceedings of the National Academy of Sciences.
[43] V. Sogos,et al. Differentiation of single cell derived human mesenchymal stem cells into cells with a neuronal phenotype: RNA and microRNA expression profile , 2011, Molecular Biology Reports.
[44] Mesenchymal Stromal Cells , 2013, Stem Cell Biology and Regenerative Medicine.
[45] Nikolay Bazhanov,et al. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs) , 2010, Journal of cellular and molecular medicine.
[46] D. Prockop,et al. Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies. , 2008, Experimental hematology.
[47] P. Delafontaine,et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.
[48] G. Sukhikh,et al. Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.
[49] I. Sekiya,et al. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit , 2008, Cell and Tissue Research.
[50] D. Prockop,et al. Action at a Distance: Systemically Administered Adult Stem/Progenitor Cells (MSCs) Reduce Inflammatory Damage to the Cornea Without Engraftment and Primarily by Secretion of TNF‐α Stimulated Gene/Protein 6 , 2011, Stem cells.
[51] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[52] Arthur S Slutsky,et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. , 2010, American journal of respiratory and critical care medicine.
[53] F. Powrie,et al. Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.
[54] L. Ortiz,et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury , 2007, Proceedings of the National Academy of Sciences.
[55] Lu Fang,et al. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. , 2007, Journal of molecular and cellular cardiology.
[56] Krisztián Németh,et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.
[57] Charles N. Serhan,et al. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.
[58] P. Hematti,et al. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. , 2009, Experimental hematology.
[59] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[60] A. Burt,et al. Mitochondrial Capture by a Transmissible Cancer , 2011, Science.
[61] M. Andreeff,et al. Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.
[62] R. Tompkins,et al. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.